Posted March 20, 2014
Dr. Rudy Tanzi of Harvard Medical School/Mass General Hospital talks to David Shenk about his research into CD33 inhibitors, which show promise in curtailing the damaging brain inflammation that occurs in Alzheimer’s disease.
Alzheimer's Treatment Videos
Back to News and Events
